Healthcare provider profile · identity verified

Ted T Lee, M.D.

Family Practice · HUNTINGTON BEACH, CA · NPI 1295804292

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	236	86
Rosuvastatin Calcium	Rosuvastatin Calcium	208	71
Losartan Potassium	Losartan Potassium	167	57
Amlodipine Besylate	Amlodipine Besylate	147	56
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	138	135
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	127	36
Cephalexin	Cephalexin	113	110
Azithromycin	Azithromycin	101	96
Alprazolam	Alprazolam	95	15
Lisinopril	Lisinopril	95	40
Metformin Hcl Er	Metformin Hcl	89	36
Paxlovid	Nirmatrelvir/Ritonavir	85	85
Tamsulosin Hcl	Tamsulosin Hcl	80	30
Prednisone	Prednisone	75	65
Levothyroxine Sodium	Levothyroxine Sodium	73	28
Albuterol Sulfate Hfa	Albuterol Sulfate	68	50
Doxycycline Monohydrate	Doxycycline Monohydrate	67	63
Atenolol	Atenolol	65	19
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	65	21
Pantoprazole Sodium	Pantoprazole Sodium	64	19
Lorazepam	Lorazepam	60	suppressed
Omeprazole	Omeprazole	57	24
Ipratropium Bromide	Ipratropium Bromide	56	50
Gabapentin	Gabapentin	53	26
Trazodone Hcl	Trazodone Hcl	51	22
Triamcinolone Acetonide	Triamcinolone Acetonide	49	37
Duloxetine Hcl	Duloxetine Hcl	47	25
Ondansetron Odt	Ondansetron	45	11
Ciprofloxacin Hcl	Ciprofloxacin Hcl	44	39
Alendronate Sodium	Alendronate Sodium	43	16
Metformin Hcl	Metformin Hcl	43	13
Sertraline Hcl	Sertraline Hcl	43	11
Finasteride	Finasteride	37	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	35	16
Terazosin Hcl	Terazosin Hcl	35	12
Potassium Chloride	Potassium Chloride	34	suppressed
Meloxicam	Meloxicam	32	21
Glipizide	Glipizide	31	15
Simvastatin	Simvastatin	31	suppressed
Pradaxa	Dabigatran Etexilate Mesylate	30	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	29	11
Allopurinol	Allopurinol	27	suppressed
Furosemide	Furosemide	27	suppressed
Oseltamivir Phosphate	Oseltamivir Phosphate	25	24
Donepezil Hcl	Donepezil Hcl	24	suppressed
Fluconazole	Fluconazole	24	21
Wixela Inhub	Fluticasone Propion/Salmeterol	22	suppressed
Alvesco	Ciclesonide	21	14
Escitalopram Oxalate	Escitalopram Oxalate	21	11
Hydrocortisone	Hydrocortisone	21	suppressed
Temazepam	Temazepam	21	suppressed
Valsartan	Valsartan	21	suppressed
Azelastine Hcl	Azelastine Hcl	20	suppressed
Carvedilol	Carvedilol	20	suppressed
Spiriva Respimat	Tiotropium Bromide	20	suppressed
Clonazepam	Clonazepam	18	suppressed
Amoxicillin	Amoxicillin	17	17
Bisoprolol Fumarate	Bisoprolol Fumarate	17	suppressed
Clonidine Hcl	Clonidine Hcl	17	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	16	suppressed
Ibuprofen	Ibuprofen	16	suppressed
Jardiance	Empagliflozin	16	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	16	suppressed
Mirtazapine	Mirtazapine	16	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	15	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	14	14
Humulin N Kwikpen	Insulin Nph Human Isophane	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	14
Propranolol Hcl	Propranolol Hcl	14	suppressed
Tizanidine Hcl	Tizanidine Hcl	14	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	14	suppressed
Breyna	Budesonide/Formoterol Fumarate	13	suppressed
Hydrocortisone-Pramoxine	Hydrocortisone/Pramoxine	13	suppressed
Latanoprost	Latanoprost	13	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	13	suppressed
Morphine Sulfate	Morphine Sulfate	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	11
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	12	suppressed
Gavilyte-C	Peg3350/Sod Sulf,bicarb,cl/Kcl	12	12
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Butalbital-Acetaminophen	Butalbital/Acetaminophen	11	suppressed
Glimepiride	Glimepiride	11	suppressed
Lidocaine Hcl Viscous	Lidocaine Hcl	11	suppressed
Modafinil	Modafinil	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	11

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error